| Erythropoietin(Epoetin theta) |
EU/1/09/573/004 |
Eporatio, Solution for injection, 2000, IU, Pack: 6 |
Ratiopharm GmbH, Германия |
Merckle Biotec GmbH, Dornierstrasse 10, DE-89079 Ulm, Germany |
120.83 |
24.17 |
145 |
4% |
4.83 |
125.66 |
25.13 |
150.79 |
16% |
19.33 |
144.99 |
29 |
173.99 |
Цената се вписва в регистъра на пределните цени с решение НСР-4555/03.09.2014 ( в сила от 18.09.2014) |
НСР-3698/06.06.2014 |
23.06.2014 |
23.06.2014 |
Заличен |
2908 |
| Erythropoietin(Epoetin theta) |
EU/1/09/573/016 |
Eporatio, Solution for injection, 10000, IU, Pack: 6 |
Ratiopharm GmbH, Германия |
Merckle Biotec GmbH, Dornierstrasse 10, DE-89079 Ulm, Germany |
593.52 |
118.7 |
712.22 |
4% |
10 |
603.52 |
120.7 |
724.22 |
16% |
25 |
628.52 |
125.7 |
754.22 |
Цената се заличава с решение НСР-3573/23.05.2014 |
КЦРР-2923/20.03.2013 |
19.04.2013 |
19.04.2013 |
Заличен |
1781 |
| Erythropoietin(Epoetin theta) |
EU/1/09/573/010 |
Eporatio, Solution for injection, 5000, IU, Pack: 6 |
Ratiopharm GmbH, Германия |
Merckle Biotec GmbH, Dornierstrasse 10, DE-89079 Ulm, Germany |
335.62 |
67.12 |
402.74 |
4% |
10 |
345.62 |
69.12 |
414.74 |
16% |
25 |
370.62 |
74.12 |
444.74 |
|
КЦРР-2746/20.03.2013 |
17.04.2013 |
17.04.2013 |
Неактивен |
2911 |
| Erythropoietin(Epoetin theta) |
EU/1/09/573/006 |
Eporatio, Solution for injection, 3000, IU, Pack: 6 |
Ratiopharm GmbH, Германия |
Merckle Biotec GmbH, Dornierstrasse 10, DE-89079 Ulm, Germany |
201.37 |
40.27 |
241.64 |
4% |
8.05 |
209.42 |
41.88 |
251.3 |
16% |
25 |
234.42 |
46.88 |
281.3 |
корекц. HCP-5/09.05.2013 |
КЦРР-2746/20.03.2013 |
17.04.2013 |
17.04.2013 |
Неактивен |
2909 |
| Erythropoietin(Epoetin theta) |
EU/1/09/573/008 |
Eporatio, Solution for injection, 4000, IU, Pack: 6 |
Ratiopharm GmbH, Германия |
Merckle Biotec GmbH, Dornierstrasse 10, DE-89079 Ulm, Germany |
268.5 |
53.7 |
322.2 |
4% |
10 |
278.5 |
55.7 |
334.2 |
16% |
25 |
303.5 |
60.7 |
364.2 |
корекц. HCP-6/09.05.2013 |
КЦРР-2746/20.03.2013 |
17.04.2013 |
17.04.2013 |
Неактивен |
2910 |
| Erythropoietin(Epoetin theta) |
EU/1/09/573/004 |
Eporatio, Solution for injection, 2000, IU, Pack: 6 |
Ratiopharm GmbH, Германия |
Merckle Biotec GmbH, Dornierstrasse 10, DE-89079 Ulm, Germany |
134.25 |
26.85 |
161.1 |
4% |
5.37 |
139.62 |
27.92 |
167.54 |
16% |
21.48 |
161.1 |
32.22 |
193.32 |
|
КЦРР-2746/20.03.2013 |
17.04.2013 |
17.04.2013 |
Неактивен |
2908 |
| erythropoietin (Epoetin alfa) |
1390/14.01.2008 г. |
EPREX, Solution for injection, 10000 IU/1.0 ml, IU, Pack: 6 |
Johnson & Johnson d.o.o., Словения |
Centocor B.V., The Netherlands; Vetter Pharma-Ferrtigung GmbH-CoKG, Germany |
673.47 |
134.69 |
808.16 |
4% |
10 |
683.47 |
136.69 |
820.16 |
16% |
25 |
708.47 |
141.69 |
850.16 |
НСР-12181/27.03.2017 |
КЦРР-2811/20.03.2013; НСР-12181/27.03.2017 |
21.05.2013 |
02.05.2017 |
Заличен |
1846 |
| erythropoietin (Epoetin alfa) |
1390/14.01.2008 г. |
EPREX, Solution for injection, 10000 IU/1.0 ml, IU, Pack: 6 |
Johnson & Johnson d.o.o., Словения |
Centocor B.V., The Netherlands; Vetter Pharma-Ferrtigung GmbH-CoKG, Germany |
673.47 |
134.69 |
808.16 |
4% |
10 |
683.47 |
136.69 |
820.16 |
16% |
25 |
708.47 |
141.69 |
850.16 |
|
КЦРР-2811/20.03.2013 |
21.05.2013 |
21.05.2013 |
Неактивен |
1846 |
| Erythropoietin |
1390/14.01.2008 г. |
EPREX, Solution for injection, 10000 IU/1.0 ml, IU, Pack: 6 |
Johnson & Johnson d.o.o., Словения |
Centocor B.V., The Netherlands; Vetter Pharma-Ferrtigung GmbH-CoKG, Germany |
673.47 |
134.69 |
808.16 |
4% |
10 |
683.47 |
136.69 |
820.16 |
16% |
25 |
708.47 |
141.69 |
850.16 |
|
КЦРР-2811/20.03.2013 |
21.05.2013 |
21.05.2013 |
Неактивен |
1846 |
| Erythropoietin |
1390/14.01.2008 г. |
EPREX, Solution for injection, 10000 IU/1.0 ml, IU, Pack: 6 |
Johnson & Johnson d.o.o., Словения |
Centocor B.V., The Netherlands; Vetter Pharma-Ferrtigung GmbH-CoKG, Germany |
964.01 |
192.8 |
1156.81 |
4% |
10 |
974.01 |
194.8 |
1168.81 |
16% |
25 |
999.01 |
199.8 |
1198.81 |
|
КЦ-380/07.01.2009 |
27.01.2009 |
27.01.2009 |
Неактивен |
1846 |
| Erythropoietin |
1394/14.01.2008 г. |
EPREX, Solution for injection, 4000, IU, Pack: 6 |
Johnson & Johnson d.o.o., Словения |
Centocor B.V., The Netherlands; Vetter Pharma-Ferrtigung GmbH-CoKG, Germany |
385.49 |
77.1 |
462.59 |
4% |
10 |
395.49 |
79.1 |
474.59 |
16% |
25 |
420.49 |
84.1 |
504.59 |
цената се заличава с решение НСР-581/23.07.2013 |
КЦ-380/07.01.2009 |
27.01.2009 |
27.01.2009 |
Заличен |
405 |
| Erythropoietin |
1395/14.01.2008 г. |
EPREX, Solution for injection, 3000, IU, Pack: 6 |
Johnson & Johnson d.o.o., Словения |
Centocor B.V., The Netherlands; Vetter Pharma-Ferrtigung GmbH-CoKG, Germany |
289.17 |
57.83 |
347 |
4% |
10 |
299.17 |
59.83 |
359 |
16% |
25 |
324.17 |
64.83 |
389 |
цената се заличава с решение НСР-582/23.07.2013 |
КЦ-380/07.01.2009 |
27.01.2009 |
27.01.2009 |
Заличен |
404 |
| Erythropoietin |
1396/14.01.2008 г. |
EPREX, Solution for injection, 2000, IU, Pack: 6 |
Johnson & Johnson d.o.o., Словения |
Centocor B.V., The Netherlands; Vetter Pharma-Ferrtigung GmbH-CoKG, Germany |
195.54 |
39.11 |
234.65 |
4% |
7.82 |
203.36 |
40.67 |
244.03 |
16% |
25 |
228.36 |
45.67 |
274.03 |
цената се заличава с решение НСР-583/23.07.2013 |
КЦ-380/07.01.2009 |
27.01.2009 |
27.01.2009 |
Заличен |
403 |
| Erythropoietin |
1397/14.01.2008 г. |
EPREX, Solution for injection, 1000, IU, Pack: 6 |
Johnson & Johnson d.o.o., Словения |
Centocor B.V., The Netherlands; Vetter Pharma-Ferrtigung GmbH-CoKG, Germany |
90.32 |
18.06 |
108.38 |
4% |
3.61 |
93.93 |
18.79 |
112.72 |
16% |
14.45 |
108.38 |
21.68 |
130.06 |
цената се заличава с решение НСР-584/23.07.2013 |
КЦ-380/07.01.2009 |
27.01.2009 |
27.01.2009 |
Заличен |
402 |
| Eptifibatide |
EU/1/15/1065/001 |
Eptifibatide Accord, Solution for injection, 0.75 mg/ml-100 ml, -, Pack: 1 vial |
Accord Healthcare Limited, Обединено Кралство |
Accord Healthcare Limited, Обединено кралство; Wessling Hungary Kft, Унгария |
48.09 |
9.62 |
57.71 |
4% |
1.92 |
50.01 |
10 |
60.01 |
16% |
7.69 |
57.7 |
11.54 |
69.24 |
|
НСР-16719/30.08.2018 |
14.09.2018 |
02.10.2018 |
Активен |
16260 |
| Eptifibatide |
EU/1/15/1065/002 |
Eptifibatide Accord, Solution for injection, 2 mg/ml-10 ml, -, Pack: 1 vial |
Accord Healthcare Limited, Обединено Кралство |
Accord Healthcare Limited, Обединено кралство; Wessling Hungary Kft, Унгария |
17.86 |
3.57 |
21.43 |
6% |
1.07 |
18.93 |
3.79 |
22.72 |
18% |
3.21 |
22.14 |
4.43 |
26.57 |
|
НСР-16239/27.07.2018 |
11.08.2018 |
02.09.2018 |
Активен |
16196 |
| Ciclosporin |
II-10129/ 08.12.2004 |
EQUORAL, Capsule, soft, 50, mg, Pack: 50 |
Teva Czech Industries s.r.o., Чешка република |
Teva Czech Industries s.r.o, Czech Republic |
43.15 |
8.63 |
51.78 |
4% |
1.73 |
44.88 |
8.98 |
53.86 |
16% |
6.9 |
51.78 |
10.36 |
62.14 |
Цената се заличава с решение НСР-3164/27.03.2014(допуска предварително изпълнение) |
НСР-1812/25.11.2013 |
11.12.2013 |
11.12.2013 |
Заличен |
2296 |
| Ciclosporin |
№ 9231 / 01.04.2010 |
EQUORAL, Capsule, soft, 100, mg, Pack: 50 |
Teva Czech Industries s.r.o., Чешка република |
Teva Czech Industries s.r.o., Czech Republic |
74.79 |
14.96 |
89.75 |
4% |
2.99 |
77.78 |
15.56 |
93.34 |
16% |
11.97 |
89.75 |
17.95 |
107.7 |
Цената се заличава с решение НСР-3164/27.03.2014(допуска предварително изпълнение) |
НСР-1811/25.11.2013 |
11.12.2013 |
11.12.2013 |
Заличен |
2297 |
| Ciclosporin |
II-10128/ 08.12.2004 |
EQUORAL, Capsule, soft, 25, mg, Pack: 50 |
Teva Czech Industries s.r.o., Чешка република |
Teva Czech Industries s.r.o, Czech Republic |
21.96 |
4.39 |
26.35 |
6% |
1.32 |
23.28 |
4.66 |
27.94 |
18% |
3.95 |
27.23 |
5.45 |
32.68 |
Цената се заличава с решение НСР-3164/27.03.2014(допуска предварително изпълнение) |
НСР-1806/25.11.2013 |
11.12.2013 |
11.12.2013 |
Заличен |
2295 |
| Ciclosporin |
№ 9231 / 01.04.2010 |
EQUORAL, Capsule, soft, 100, mg, Pack: 50 |
Teva Czech Industries s.r.o., Чешка република |
Teva Czech Industries s.r.o., Czech Republic |
111.83 |
22.37 |
134.2 |
4% |
4.47 |
116.3 |
23.26 |
139.56 |
16% |
17.89 |
134.19 |
26.84 |
161.03 |
|
КЦРР-226/27.02.2012 |
19.03.2012 |
19.03.2012 |
Неактивен |
2297 |
| Ciclosporin |
II-10130/ 08.12.2004 |
EQUORAL, Capsule, soft, 100, mg, Pack: 50 |
Teva Czech Industries s.r.o., Чешка република |
IVAX Pharmaceuticals s.r.o., Czech Republic |
139.84 |
27.97 |
167.81 |
6% |
8.39 |
148.23 |
29.65 |
177.88 |
18% |
25.17 |
173.4 |
34.68 |
208.08 |
КЦ-3023/26.10.2011 промяна на обстоятелства |
КЦ-700/09.03.2009 |
24.03.2009 |
24.03.2009 |
Неактивен |
2297 |
| Ciclosporin |
II-10129/ 08.12.2004 |
EQUORAL, Capsule, soft, 50, mg, Pack: 50 |
Teva Czech Industries s.r.o., Чешка република |
Teva Czech Industries s.r.o, Czech Republic |
70.02 |
14 |
84.02 |
4% |
2.8 |
72.82 |
14.56 |
87.38 |
16% |
11.2 |
84.02 |
16.8 |
100.82 |
КЦ-3023/26.10.2011 . КЦРР-302/15.03.2012 промяна на обстоятелства |
КЦ-700/09.03.2009 |
24.03.2009 |
24.03.2009 |
Неактивен |
2296 |
| Ciclosporin |
II-10128/ 08.12.2004 |
EQUORAL, Capsule, soft, 25, mg, Pack: 50 |
Teva Czech Industries s.r.o., Чешка република |
Teva Czech Industries s.r.o, Czech Republic |
35.01 |
7 |
42.01 |
4% |
1.4 |
36.41 |
7.28 |
43.69 |
16% |
5.6 |
42.01 |
8.4 |
50.41 |
КЦ-3023/26.10.2011 . КЦРР-302/15.03.2012 промяна на обстоятелства |
КЦ-700/09.03.2009 |
24.03.2009 |
24.03.2009 |
Неактивен |
2295 |
| Ciclosporin |
II-10127/ 08.12.2004 |
EQUORAL, Oral solution, 100 mg/ ml - 50 ml, mg, Pack: 1 |
Teva Czech Industries s.r.o., Чешка република |
Teva Czech Industries s.r.o, Czech Republic |
70.19 |
14.04 |
84.23 |
4% |
2.81 |
73 |
14.6 |
87.6 |
16% |
11.23 |
84.23 |
16.85 |
101.08 |
Цената се заличава с решение НСР-2720/06.02.2014 |
НСР-1801/25.11.2013 |
11.12.2013 |
11.12.2013 |
Заличен |
2287 |
| Ciclosporin |
II-10127/ 08.12.2004 |
EQUORAL, Oral solution, 100 mg/ ml - 50 ml, mg, Pack: 1 |
Teva Czech Industries s.r.o., Чешка република |
Teva Czech Industries s.r.o, Czech Republic |
139.84 |
27.97 |
167.81 |
4% |
5.59 |
145.43 |
29.09 |
174.52 |
16% |
22.37 |
167.8 |
33.56 |
201.36 |
КЦ-3023/26.10.2011 . КЦРР-302/15.03.2012 промяна на обстоятелства |
КЦ-700/09.03.2009 |
24.03.2009 |
24.03.2009 |
Неактивен |
2287 |